Understanding and learning from the diversification of cannabis supply laws

Understanding and learning from the diversification of cannabis supply laws
复制标题

DOI:
10.1111/add.13623
复制
发表时间:
2017-07-01
期刊:
影响因子:
6
通讯作者:
Pacula, Rosalie Liccardo
Pacula, Rosalie Liccardo
中科院分区:
医学1区
文献类型:
--
作者:
Kilmer, Beau;Pacula, Rosalie Liccardo

文献摘要

被引文献

相似文献

背景和目的在世界各地的不同司法管辖区,对生产、分销和销售大麻的禁令正在放松。本文介绍了大麻供应法律的多样化,并讨论了挑战和机遇,从这些changes.MethodsWe文件中学习大麻供应法律的变化,法律上合法化大麻生产用于医疗和/或非医疗目的(不包括工业大麻)在澳大拉西亚,欧洲,北美和南美。我们还强调挑战,以评估这些法律的变化的基础上,我们的经验研究大麻的法律和政策在美国。FindingsAs八月2016,两个国家已经通过法律,以合法化大规模大麻生产用于非医疗目的在国家(乌拉圭)或国家以下一级(美国四个州)。至少还有9个国家在法律上允许(或很快将允许)为医疗目的供应大麻。大麻供应法律的大部分变化发生在2010年以来。在大多数国家的数据是不够的,严格评估大麻供应laws.ConclusionThe证据基础的变化,评估大麻供应法律仍然薄弱。工作重点应是收集关于消费数量和市场交易的信息,并验证自我报告调查。
Background and aimsProhibitions on producing, distributing and selling cannabis are loosening in various jurisdictions around the world. This paper describes the diversification of cannabis supply laws and discusses the challenges to and opportunities for learning from these changes.MethodsWe document changes in cannabis supply laws that de jure legalized cannabis production for medical and/or non-medical purposes (excluding industrial hemp) in Australasia, Europe, North America and South America. We also highlight challenges to evaluating these legal changes based on our experiences studying cannabis laws and policies in the United States.FindingsAs of August 2016, two countries have passed laws to legalize large-scale cannabis production for non-medical purposes at the national (Uruguay) or subnational level (four US states). At least nine other countries legally allow (or will soon allow) cannabis to be supplied for medicinal purposes. Most of the changes in cannabis supply laws have occurred since 2010. The data available in most countries are inadequate for rigorously evaluating the changes in cannabis supply laws.ConclusionThe evidence base for assessing changes in cannabis supply laws remains weak. Efforts should focus upon collecting information about quantities consumed and market transactions as well as validating self-report surveys.